Population Studies and Surveillance, Cancer Care Ontario, 620 University Avenue, Toronto, Ontario, Canada M5G 2L7.
Carcinogenesis. 2012 Apr;33(4):818-27. doi: 10.1093/carcin/bgs028. Epub 2012 Feb 2.
Individual susceptibility to the toxic effects of cigarette smoke may be modified by inherited variability in carcinogen metabolism. The purpose of the present study was to investigate pancreatic cancer risk associated with cigarette smoking and 33 variants within carcinogen metabolism genes and examine whether these variants modify the association between smoking and pancreatic cancer. A population-based study was conducted with 455 pancreatic cancer cases and 893 controls. Epidemiological and smoking data were collected from questionnaires and variants were genotyped by mass spectrometry. Age- and sex-adjusted odds ratio (ASOR) and multivariate-adjusted odds ratio (MVOR) estimates were obtained using multivariate logistic regression, and interactions between each variant and smoking were investigated. Current smoker status [MVOR = 2.29, 95% confidence interval (95% CI): 1.62, 3.22], 10-27 pack-years (MVOR = 1.57, 95% CI: 1.13, 2.18), >27 pack-years (MVOR = 1.77, 95% CI: 1.27, 2.46) and longer durations of smoking (19-32 years: MVOR = 1.46, 95% CI: 1.05, 2.05; >32 years: MVOR = 1.78, 95% CI: 1.30, 2.45) were associated with increased pancreatic cancer risk. CYP1B1-4390-GG (ASOR = 0.36, 95% CI: 0.15, 0.86) and Uridine 5'-diphospho glucuronosyltransferase 1 family, polypeptide A7-622-CT (ASOR = 0.77, 95% CI: 0.60, 0.99) were associated with reduced risk. N-acetyltransferase 1-640-GT/GG (ASOR = 1.75, 95% CI: 1.00, 3.05), GSTM1 (rs737497)-GG (ASOR = 1.41, 95% CI: 1.02, 1.95), GSTM1 gene deletion (ASOR = 4.89, 95% CI: 3.52, 6.79) and glutathione S-transferase theta-1 gene deletion (ASOR = 4.41, 95% CI: 2.67, 7.29) were associated with increased risk. Significant interactions were observed between pack-years and EPHX1-415 (P = 0.04) and smoking status and N-acetyltransferase 2-857 (P = 0.03). Variants of carcinogen metabolism genes are independently associated with pancreatic cancer risk and may modify the risk posed by smoking.
个体对香烟毒性作用的敏感性可能会受到致癌物代谢遗传变异的影响。本研究的目的是调查与吸烟相关的胰腺癌风险以及 33 个致癌物代谢基因内的变体,并检验这些变体是否会改变吸烟与胰腺癌之间的关联。这项基于人群的研究共纳入了 455 例胰腺癌病例和 893 例对照。通过问卷调查收集流行病学和吸烟数据,并通过质谱法对变体进行基因分型。采用多变量逻辑回归获得年龄和性别调整的比值比(ASOR)和多变量调整的比值比(MVOR)估计值,并研究每个变体与吸烟之间的相互作用。目前吸烟者的患病风险[MVOR = 2.29,95%置信区间(95%CI):1.62,3.22]、10-27 包年(MVOR = 1.57,95%CI:1.13,2.18)、>27 包年(MVOR = 1.77,95%CI:1.27,2.46)和更长的吸烟时间(19-32 年:MVOR = 1.46,95%CI:1.05,2.05;>32 年:MVOR = 1.78,95%CI:1.30,2.45)与胰腺癌风险增加相关。CYP1B1-4390-GG(ASOR = 0.36,95%CI:0.15,0.86)和尿苷 5'-二磷酸葡萄糖醛酸基转移酶 1 家族多肽 A7-622-CT(ASOR = 0.77,95%CI:0.60,0.99)与风险降低相关。N-乙酰基转移酶 1-640-GT/GG(ASOR = 1.75,95%CI:1.00,3.05)、GSTM1(rs737497)-GG(ASOR = 1.41,95%CI:1.02,1.95)、GSTM1 基因缺失(ASOR = 4.89,95%CI:3.52,6.79)和谷胱甘肽 S-转移酶 theta-1 基因缺失(ASOR = 4.41,95%CI:2.67,7.29)与风险增加相关。还观察到了 EPHX1-415 与吸烟包年数(P = 0.04)以及 N-乙酰基转移酶 2-857 与吸烟状态(P = 0.03)之间的显著交互作用。致癌物代谢基因的变体与胰腺癌风险独立相关,并且可能会改变吸烟造成的风险。